Brand new research information

As we work hard this time of year to increase participation and support for Team Shelby, it is natural that people have more questions. Even long-time supporters wonder what's going on with all the research? And just what does the JDRF fund anyway?

In the latest edition of the JDRF Research Frontline, they carried three short items describing the breadth of the work being done in regard to Type I Diabetes. They include:

• FDA approval of an antibotic to fight the most common form of diabetes-related blindness,
  
• advancements toward a continual blood sugar monitoring system, and
  
• groundbreaking work in the use of adult stem cells.

I've posted the items in the Team Shelby Research Corner. Here's a link that should take you to a pdf of the newsletter, as well.

Printing out Frontline for distribution to potential donors is a great way to express clearly and authoritatively what the JDRF is doing daily to fight this disease.